Copied to clipboard!
Multi-Platform Analysis of Matched Well- and Dedifferentiated Tumors Identify Novel Drivers of Liposarcomagenesis
This study assessed genomic events that define initiation and progression in well-differentiated and dedifferentiated liposarcoma. Paired samples from serial surgeries performed for low (well-differentiated) and high (dedifferentiated) disease were assessed for copy number alterations, gene expression and mutations (using next-generation sequencing) to nominate events potentially governing early initiation and subsequent disease progression. Samples were validated in a larger cohort of samples with available array-based data and via a custom capture array to assess the rate at which such events are observed in the disease as a whole. The study data supports a model of liposarcomagenesis in which:
- Early initiation is governed by copy number alterations that affect aberrant gene expression in well-differentiated liposarcoma
- Recurrent amplification of 6q23-25 in well-differentiated tumors is associated with local recurrence
- 6q23-25 amplification appears to exert oncogenic effects by altering expression of TAB2
- Dedifferentiation is characterized by high rates of ATRX mutation, by loss of 13q and by amplification of 8q12-21.
- 13q loss appears not to affect expression of RB1 but may be associated with dedifferentiation by modulating novel tumor suppressors MYCBP2 and IRS2.
- Type: Cohort
- Archive: The database of Genotypes and Phenotypes (dbGaP)
